Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Vascular Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hawari, F. I
Right arrow Articles by Izzo, J. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawari, F. I
Right arrow Articles by Izzo, J. L, Jr
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Heparin attenuates norepinephrine-induced venoconstriction

Feras I Hawari

Department of Medicine, State University of New York at Buffalo, Buffalo, NY, USA

Barbara E Shykoff

Department of Medicine, State University of New York at Buffalo, Buffalo, NY, USA

Joseph L Izzo, Jr

Department of Medicine, State University of New York at Buffalo, Buffalo, NY, USA

Reversal by heparin of norepinephrine-induced constriction of normal hand veins was studied. Venous size was measured using a linear variable differential transformer (LVDT) during infusions of saline, norepinephrine, insulin and norepinephrine, and graded doses of heparin with norepinephrine. Heparin reduced the venoconstrictive effects of norepinephrine (p, 0.01), with the effects beginning at 18.5 nmol/min (0.05 U/min) and reaching a maximum between 185 nmol/min and 1.85 mmol/min (0.5 and 5 U/min). Maximal heparin-induced venorelaxation correlated with the maximal insulin effect within individuals (r = 0.8, p, 0.01) and was unchanged by the addition of insulin. Methylene blue, a non-specific inhibitor of the nitric oxide cGMP cascade, reduced heparin-induced venorelaxation. In conclusion, heparin in either physiologic or pharmacologic concentrations attenuated norepinephrine-induced venoconstriction. A common mechanism of venorelaxation by heparin and insulin is not excluded given the correlation and lack of additivity of maximum effects and their inhibition by methylene blue.

Key Words: endothelium • hand veins • LVDT • vascular reactivity • vasodilation

Vascular Medicine, Vol. 3, No. 2, 95-100 (1998)
DOI: 10.1177/1358836X9800300202
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 pdiHome page
P. Margetts
HEPARIN AND THE PERITONEAL MEMBRANE
Perit. Dial. Int., January 1, 2009; 29(1): 16 - 19.
[Full Text] [PDF]

Home page
 Vasc MedHome page
B. E Shykoff, F. I Hawari, and J. L Izzo Jr
Diameter, pressure and compliance relationships in dorsal hand veins
Vascular Medicine, May 1, 2001; 6(2): 97 - 102.
[Abstract] [PDF]

Home page
 J. Appl. Physiol.Home page
D. J. Horstman, L. G. Fischer, P. C. Kouretas, R. L. Hannan, and G. F. Rich
Role of nitric oxide in heparin-induced attenuation of hypoxic pulmonary vascular remodeling
J Appl Physiol, May 1, 2002; 92(5): 2012 - 2018.
[Abstract] [Full Text] [PDF]